Skip to main content
. 2011 Sep 30;43(3):148–153. doi: 10.4143/crt.2011.43.3.148

Table 4.

Phase II studies on irinotecan, 5-FU, and LV combination chemotherapy for advanced gastric cancer

graphic file with name crt-43-148-i004.jpg

5-FU, 5-fluorouracil; LV, leucovorin; RR, response rate; SD, stable diseases; TTP, time to progression; OS, overall survival; I, irinotecan; D, day.